Artigo Acesso aberto Revisado por pares

Towards an elastin-based hydrogel platform for the repair of myocardial infarction

2016; Frontiers Media; Volume: 4; Linguagem: Inglês

10.3389/conf.fbioe.2016.01.02028

ISSN

2296-4185

Autores

Paolo Contessotto, Gesmi Milcovich, Renza Spelat, Marsico Grazia, Chaturvedi Ankit, Doriana Orbanić, Tatjana Flora, Da Costa Mark, Mindaugas Rackauskas, Amenitsch Heinz, Mccartin Mike, Rodriguez-Cabello Jos� Carlos, Joshi Lokesh, Peter Dockery, Michelle Kilcoyne, Pandit Abhay,

Tópico(s)

Cardiac Structural Anomalies and Repair

Resumo

Event Abstract Back to Event Towards an elastin-based hydrogel platform for the repair of myocardial infarction Paolo Contessotto1, Gesmi Milcovich1*, Renza Spelat1*, Grazia Marsico1*, Ankit Chaturvedi2*, Doriana Orbanić3*, Tatjana Flora3*, Mark Da Costa1, 4, Mindaugas Rackauskas5*, Heinz Amenitsch6*, Mike Mccartin2*, José Carlos Rodriguez-Cabello3*, Lokesh Joshi7*, Peter Dockery8*, Michelle Kilcoyne7, 9* and Abhay Pandit1 1 National University of Ireland, CURÁM, Centre for Research in Medical Devices, Ireland 2 Vivasure Medical Limited, Ireland 3 Universidad de Valladolid, Ciber-BBN, G.I.R. Bioforge, Spain 4 University College Hospital Galway, Ireland 5 Mater Misericordiae University Hospital, Ireland 6 Institut of Inorganic Chemistry, Graz University of Technology, Austria 7 National University of Ireland, Glycoscience Group, Ireland 8 National University of Ireland, Anatomy, School of Medicine, Ireland 9 National University of Ireland, Microbiology, School of Natural Sciences, Ireland Introduction Elastin is one of the main components of the extracellular matrix (ECM) and has been investigated as a potential therapeutic biomaterial in the treatment of several diseases, such as myocardial infarction [1]. The intrinsic physical elastic properties of elastin-like recombinamers and their interaction with relevant glycosylation in the ECM can be exploited by developing a tailored biomaterial. The objectives of this study are to fabricate an injectable elastin-based hydrogel based on the glycoprofile in normal and ischemic cardiac muscle. We hypothesize that a naturally-inspired glyco-functionalised injectable elastin-like hydrogel will preserve cardiac functionality by the enhancement of cardiomyocyte proliferation. Materials and methods Hydrogel fabrication: Elastin-like recombinamers (ELRs) were functionalised with azide and cyclooctyne groups for crosslinking. The hydrogel construct was characterized by rheology, NMR, and Synchrotron Radiation SAXS (SRSAXS). Moreover, further degradation studies were conducted using elastase (Sigma). The hydrogel was stained with 1% Alcian Blue solution before epicardial injection in the myocardium of a healthy lamb heart. Glycoprofile analysis: Lectin histochemistry and lectin microarray analyses were performed on left ventricle cryosections from healthy male Lewis and Dark Agouti rats (n=5). Myocardial infarction in vivo models: Induction of myocardial infarction is being performed on Romanov sheep (n=7) to better mimic human conditions [2], while cryoinjury method is adopted as a method to reproduce the ischemic event in Danio rerio [3]. All animals were sacrificed after approval by the respective Institutional Ethics Committee. Statistical analysis was performed using Minitab Software. Results and Discussion ELRs-based hydrogel was fabricated and optimized; the optimal gelling time before injection was found between 10 and 12 minutes at room temperature and its successful integration across the cardiomyocytes confirmed by hematoxylin and eosin (H&E) and Wheat Germ Agglutinin (WGA) lectin staining, confirming its potential application for in vivo studies [4]. Glycoprofile analysis was carried out in healthy myocardial left ventricle rat tissue, using a panel of lectins which bind to specific glycan residues that are involved in cardiac signalling and functionality, such as sialic acids (Neu) and N-acetylglucosamine (GlcNAc) [5]. Distinct patterns of binding due to the differential glycosylation in capillaries and cardiomyocytes membranes were found by lectin histochemistry analysis and their presence further validated by lectin microarray technology. Conclusion An ELRs-based hydrogel was optimised for injection through the myocardial walls. The assessment of the glyco-profiles in healthy myocardial tissue was completed to have a baseline before further analysis in the ischemic samples. Glycoprofile comparative analysis between a non-regenerative and a self-regenerative model in Danio rerio can further enable us to tailor our system towards a regenerative system. Seventh Framework Programme Grant Agreement no.: 317304; Centre for Microscopy & Imaging at the National University of Ireland Galway funded by Irish Government’s Programme for Research in Third Level Institutions, Cycles 4 and 5, National Development Plan 2007-2013References:[1] MacEwan, S., Chilkoti, A., 2014, Journal of Controlled Release; 190:314-30[2] Schmitto, J. D., Mokashi, S. A., Lee, L. S., Laurence, R., Schotola, H., Coelho-Filho, O., Rajab, T. K., Kwong, R., Morton Bolman III, R., Quintel., M., Cohn, L. H., Chen, F. Y., 2010, Artificial Organs; 34(11):918-22[3] Chablais, F., Veit, J., Rainer, G., Jazwinska, A., 2011, BMC Developmental Biology; 11:21[4] Chilkoti, A., Christensen, T., MacKay, J. A., 2006, Current Opinion in Chemical Biology; 10(6):652-7[5] Schwetz, T. A., Norring, S. A., Ednie, A. R., Bennett, E. S., 2011, Journal of Biological Chemistry; 286(6):4123-32 Keywords: Extracellular Matrix, Hydrogel, MYOCARDIAL TISSUE, Heart repair Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016. Presentation Type: New Frontier Oral Topic: Biomaterials to modulate biological processes involved in host response Citation: Contessotto P, Milcovich G, Spelat R, Marsico G, Chaturvedi A, Orbanić D, Flora T, Da Costa M, Rackauskas M, Amenitsch H, Mccartin M, Rodriguez-Cabello J, Joshi L, Dockery P, Kilcoyne M and Pandit A (2016). Towards an elastin-based hydrogel platform for the repair of myocardial infarction. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.02028 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 27 Mar 2016; Published Online: 30 Mar 2016. * Correspondence: Dr. Gesmi Milcovich, National University of Ireland, CURÁM, Centre for Research in Medical Devices, Galway, Ireland, Email1 Dr. Renza Spelat, National University of Ireland, CURÁM, Centre for Research in Medical Devices, Galway, Ireland, Email2 Dr. Grazia Marsico, National University of Ireland, CURÁM, Centre for Research in Medical Devices, Galway, Ireland, Email3 Dr. Ankit Chaturvedi, Vivasure Medical Limited, Galway, Ireland, Email4 Dr. Doriana Orbanić, Universidad de Valladolid, Ciber-BBN, G.I.R. Bioforge, Valladolid, Spain, Email5 Dr. Tatjana Flora, Universidad de Valladolid, Ciber-BBN, G.I.R. Bioforge, Valladolid, Spain, Email6 Dr. Mindaugas Rackauskas, Mater Misericordiae University Hospital, Dublin, Ireland, Email7 Dr. Heinz Amenitsch, Institut of Inorganic Chemistry, Graz University of Technology, Graz, Austria, Email8 Dr. Mike Mccartin, Vivasure Medical Limited, Galway, Ireland, Email9 Dr. José Carlos Rodriguez-Cabello, Universidad de Valladolid, Ciber-BBN, G.I.R. Bioforge, Valladolid, Spain, Email10 Dr. Lokesh Joshi, National University of Ireland, Glycoscience Group, Galway, Ireland, Email11 Dr. Peter Dockery, National University of Ireland, Anatomy, School of Medicine, Galway, Ireland, Email12 Dr. Michelle Kilcoyne, National University of Ireland, Glycoscience Group, Galway, Ireland, Email13 Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Paolo Contessotto Gesmi Milcovich Renza Spelat Grazia Marsico Ankit Chaturvedi Doriana Orbanić Tatjana Flora Mark Da Costa Mindaugas Rackauskas Heinz Amenitsch Mike Mccartin José Carlos Rodriguez-Cabello Lokesh Joshi Peter Dockery Michelle Kilcoyne Abhay Pandit Google Paolo Contessotto Gesmi Milcovich Renza Spelat Grazia Marsico Ankit Chaturvedi Doriana Orbanić Tatjana Flora Mark Da Costa Mindaugas Rackauskas Heinz Amenitsch Mike Mccartin José Carlos Rodriguez-Cabello Lokesh Joshi Peter Dockery Michelle Kilcoyne Abhay Pandit Google Scholar Paolo Contessotto Gesmi Milcovich Renza Spelat Grazia Marsico Ankit Chaturvedi Doriana Orbanić Tatjana Flora Mark Da Costa Mindaugas Rackauskas Heinz Amenitsch Mike Mccartin José Carlos Rodriguez-Cabello Lokesh Joshi Peter Dockery Michelle Kilcoyne Abhay Pandit PubMed Paolo Contessotto Gesmi Milcovich Renza Spelat Grazia Marsico Ankit Chaturvedi Doriana Orbanić Tatjana Flora Mark Da Costa Mindaugas Rackauskas Heinz Amenitsch Mike Mccartin José Carlos Rodriguez-Cabello Lokesh Joshi Peter Dockery Michelle Kilcoyne Abhay Pandit Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.

Referência(s)